BioCorteX vs Uncovr
BioCorteX vs Uncovr, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioCorteX is on 49/100 and Uncovr on 52/100.
Where each one leads
BioCorteX
Leads on none of the measures we hold for both companies.
Uncovr
- our overall score: 52/100 against 49/100
- funding raised: $7.0M against $5.0M
At a glance
| Measure | BioCorteX | Uncovr |
|---|---|---|
| What it is | BioCorteX is a tech bio company developing precision medicine solutions using AI-powered in-silico simulations to understand drug-bacteria interactions and personalize treatments. | AI-powered surgical documentation and workflow intelligence. |
| Category | Artificial Intelligence, Biotech, MedTech, HealthTech | Artificial Intelligence, Healthcare, Surgical Technology, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2021 | 2025 |
| Headquarters | London, United Kingdom | San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | BioCorteX | Uncovr |
|---|---|---|
| Total funding | $5.0M | $7.0M |
| Latest round | Seed | Seed |
| LinkedIn followers | Not published | 1,041 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BioCorteX | Uncovr |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 49/100 | 52/100 |
| Traction | 33/100 | 34/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 2/100 | 37/100 |
| Quality | 58/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | D (45/100) |
| Domain ratingLink authority, 0-100 | 26/100 | 25/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BioCorteX | Uncovr |
|---|---|---|
| CMS | Not detected | Framer |
BioCorteX vs Uncovr: common questions
Which is better, BioCorteX or Uncovr?
On our 0-100 score Uncovr rates higher (52/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do BioCorteX and Uncovr compare on the numbers?
Uncovr leads on our overall score (52/100 against 49/100), funding raised ($7.0M against $5.0M).
Read the full BioCorteX review and pricing or the Uncovr review and pricing. You can also browse other BioCorteX alternatives we track.